Abstract: The present subject matter relates to the use of one or more inhibitors to treat a disease, e.g., cancer, in a subject. The presently disclosed subject matter provides for compositions and methods for treating a subject using a cancer transition inhibitor, an inhibitor that reduces the expression level of a marker of the transition of adipose-derived stromal cells (ASCs) to COL11A1-expressing cancer-associated fibroblasts (CAFs).
Type:
Application
Filed:
December 28, 2021
Publication date:
July 28, 2022
Applicants:
The Trustees of Columbia University in the City of New York, The University of Texas Health Science Center at Houston
Abstract: Prion peptides exhibiting structural isomerism to wild-type prion peptide are disclosed. The invention further discloses methods of making prion isomers, compositions comprising prion isomers, and compositions and products comprising antibody to a prion isomer. Methods for screening a patient for a neuro-degenerative disease, and methods for treating a patient afflicted with a neuro-degenerative disease are also disclosed.
Type:
Grant
Filed:
December 19, 2001
Date of Patent:
May 31, 2005
Assignee:
University of Texas Health Science Center Houston
Abstract: A method of treating severe brain trauma with hypothermia includes the introduction of specified medication to reduce the risk of cardiac arrhythmia and other malfunctions that may result from the brain trauma or the hypothermia. The method further includes a protocol for the treatment which defines time, temperature, rate of change of temperature, and the timing of the introduction of medications. Finally, rigidly controlled rewarming reduces the incidence of rewarming shock in recovering patients.
Type:
Grant
Filed:
September 20, 1994
Date of Patent:
January 23, 1996
Assignee:
University of Texas Health Science Center Houston